Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Bhatt, Deepak L, Fox, Keith A A, Hacke, Werner, Berger, Peter B, Black, Henry R, Boden, William E, Cacoub, Patrice, Cohen, Eric A, Creager, Mark A, Easton, J Donald, Flather, Marcus D, Haffner, Steven M, Hamm, Christian W, Hankey, Graeme J, Johnston, S Claiborne, Mak, Koon-Hou, Mas, Jean-Louis, Montalescot, Gilles, Pearson, Thomas A, Steg, P Gabriel, Steinhubl, Steven R, Weber, Michael A, Brennan, Danielle M, Fabry-Ribaudo, Liz, Booth, Joan, Topol, Eric J and , CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine, 354 (16). pp. 1706-17. ISSN 0028-4793

Full text not available from this repository. (Request a copy)

Abstract

Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events.

Item Type: Article
Additional Information: Copyright 2006 Massachusetts Medical Society.
Uncontrolled Keywords: adult,aged,aged, 80 and over,aspirin,cardiovascular diseases,data interpretation, statistical,double-blind method,drug therapy, combination,female,hemorrhage,humans,male,middle aged,myocardial infarction,platelet aggregation inhibitors,proportional hazards models,prospective studies,risk factors,stroke,thrombosis,ticlopidine
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 20 Jan 2014 16:16
Last Modified: 23 Jan 2019 12:41
URI: https://ueaeprints.uea.ac.uk/id/eprint/46281
DOI: 10.1056/NEJMoa060989

Actions (login required)

View Item